event
Global Health Centre
Tuesday
03
December
GHC Event Access to Medicines

Creative Approaches to Improving Access to Medicines Globally: Ideas from the Hepatitis C Experience

, -

Auditorium Ivan Pictet, Maison de la paix, Geneva

Add to Calendar
Add to calendar

Access to medical products is a complex global challenge at the interface between health, economics, politics and development. This one-day symposium organised in collaboration with the Swiss Federal Institute of Intellectual Property and the Federal Office of Public Health will focus on a sub-set of access to medicines challenges, using Hepatitis C virus (HCV) as an extended case study to facilitate discussions and novel thinking.

The purpose of the event is to spur fresh thinking on how to achieve innovation and global access to medicines, following up on the Swiss Federal Institute of Intellectual Property (IPI) Stakeholder Discussions in February 2018 in Bern. The case study approach is intended to advance the debate beyond generalities by focusing on a suite of specific strategies in relation to one class of health technologies, which may be an illustrative example of many new medicines to come.

 

Video Recording

    Event Materials

    Programme

     

    Introduction

    • Vinh-Kim Nguyen, Co-Director, Global Health Centre; Professor of Anthropology and Sociology, the Graduate Institute
    • Felix Addor, Deputy Director General, Federal Institute of Intellectual Property; Professor of International Negotiations, University of Bern

    Expanding National Treatment Programmes

    • Gregory Dore, Professor, Kirby Institute, University of New South Wales, Sydney
    • Heba Wanis, Researcher, Third World Network
    • Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia
    • Philip Bruggmann, Chair, Swiss Hepatitis, University of Zurich
    • Moderated by Martina Schwab, Co-head, Global Health Section, Swiss Federal Office of Public Health
       

    Evolving Innovation Models and Implications for Access

    • Rekha Ramesh, Head of Global Public Policy, Gilead Sciences
    • Victor Roy, Research Fellow, UCL Institute for Innovation and Public Purpose
    • Ari-Pekka Laitsaari, Senior Investment Officer, European Investment Bank
    • Bernard Pécoul, Executive Director, Drugs for Neglected Diseases initiative
    • Moderated by Lucas von Wattenwyl, Senior Advisor, Federal Institute of Intellectual Property
       

    Implications for Global Health Actors

    • Nora Kronig Romero, Ambassador, Swiss Federal Office of Public Health
    • Mariângela Simão, Assistant Director-General, World Health Organization
    • Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers and Associations
    • Sherine Helmy, CEO, Pharco Pharmaceuticals
    • Fifa Rahman, Board Member, NGO Delegation, UNITAID
    • Moderated by Suerie Moon, Co-Director, Global Health Centre, the Graduate Institute
       

    Synthesis of Major Themes and Closing Remarks

    • Caro van Leeuwen, Divisional Head, ECAP - Presentation of a cartoon
    • Suerie Moon, Co-Director, Global Health Centre, the Graduate Institute
    • Felix Addor, Deputy Director General, Federal Institute of Intellectual Property; Professor of International Negotiations, University of Bern
       

     

    Organised jointly with IPI and FOPH.